JP Morgan Chase
SVNT

JP Morgan Chase’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

JP Morgan Chase’s Portfolio SVNT Stock Details SVNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-18,477
Closed -$11K – 4481
2013
Q3 		$11K Sell
18,477
-12
-0.1% -$8 ﹤0.01% 4328
2013
Q2 		$10K Buy
+18,489
New +$12.9K ﹤0.01% 4345

Other funds holding SVNT

Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
FHC
First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return
PSC
Prentiss Smith & Co Brattleboro, Vermont $172M AUM 21.18% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

JP Morgan Chase's SVNT Position: Q4 2013 in Review

JP Morgan Chase sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q4 2013, closing a stake of 18,477 shares — an estimated $11K sold.

JP Morgan Chase first reported a position in SVNT in Q2 2013 and held it in 2 quarters. The position peaked at $11K in Q3 2013. 7 funds tracked by Wall St. Rank hold SVNT as of Q4 2013.

  • JP Morgan Chase reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • JP Morgan Chase sold 18,477 SAVIENT PHARMACEUTICALS INC shares in Q4 2013, an estimated $11K.
  • JP Morgan Chase first reported a position in SAVIENT PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • JP Morgan Chase's SAVIENT PHARMACEUTICALS INC position peaked at $11K in Q3 2013.
  • 7 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q4 2013.

Based on JP Morgan Chase's 13F filing for Q4 2013, filed 13 Feb 2014.